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Ryanodine receptor modulation 
by caffeine challenge modifies Na+ 
current properties in intact murine 
skeletal muscle fibres
Sahib S. Sarbjit-Singh1,3, Hugh R. Matthews1,3 & Christopher L.-H. Huang1,2*
We investigated effects of the ryanodine receptor (RyR) modulator caffeine on Na+ current (Ina) 
activation and inactivation in intact loose-patch clamped murine skeletal muscle fibres subject to a 
double pulse procedure. Ina activation was examined using 10-ms depolarising, V1, steps to varying 
voltages 0–80 mV positive to resting membrane potential. The dependence of the subsequent, Ina 
inactivation on V1 was examined by superimposed, V2, steps to a fixed depolarising voltage. Current-
voltage activation and inactivation curves indicated that adding 0.5 and 2 mM caffeine prior to 
establishing the patch seal respectively produced decreased (within 1 min) and increased (after ~2 min) 
peak Ina followed by its recovery to pretreatment levels (after ~40 and ~30 min respectively). These 
changes accompanied negative shifts in the voltage dependence of Ina inactivation (within 10 min) 
and subsequent superimposed positive activation and inactivation shifts, following 0.5 mM caffeine 
challenge. In contrast, 2 mM caffeine elicited delayed negative shifts in both activation and inactivation. 
These effects were abrogated if caffeine was added after establishing the patch seal or with RyR block 
by 10 μM dantrolene. These effects precisely paralleled previous reports of persistently (~10 min) 
increased cytosolic [Ca2+] with 0.5 mM, and an early peak rapidly succeeded by persistently reduced 
[Ca2+] likely reflecting gradual RyR inactivation with ≥1.0 mM caffeine. The latter findings suggested 
inhibitory effects of even resting cytosolic [Ca2+] on Ina. They suggest potentially physiologically 
significant negative feedback regulation of RyR activity on Nav1.4 properties through increased or 
decreased local cytosolic [Ca2+], Ca2+-calmodulin and FKBP12.
Skeletal muscle excitation-contraction coupling involves triggering of a Nav1.4 mediated action potential. 
This is detected by voltage-dependent transverse tubular Cav1.1 that undergoes transitions resulting in an 
allosterically-activated ryanodine receptor (RyR) mediated release of sarcoplasmic reticular (SR) Ca2+ thereby 
increasing cytosolic free Ca2+ concentration, [Ca2+]i, Recent findings have been suggestive of feedback mecha-
nisms through which downstream events in this feedforward sequence might conversely affect Nav1.4 function. 
However, many of these reports provided structural rather than functional evidence, or involved experiments 
in cell lines or isolated cultured cells. They thus provide necessary rather than sufficient evidence for the actual 
operation of Ca2+ mediated feedback mechanisms in working muscle in vivo. Few available reports examined the 
existence and properties of RyR-mediated feedback actions on Nav1.4 function in intact in situ skeletal myocytes 
particularly those directly targeting the RyR mediated Ca2+ release process.
First, Nav1.4 possesses several potential Ca2+ and calmodulin (CaM) binding or modulation sites. These 
include: (a) one or more Ca2+-binding C-terminal EF-like hand motifs1; (b) a C-terminal isoleucine-glutamine 
(IQ) domain that could bind CaM following combination of Ca2+ with CaM’s own EF-hand motifs2; (c) a III-IV 
loop Ca2+/CaM-binding site3; (d) sites phosphorylatable by CaM kinase II (CaMKII) themselves regulated by 
Ca2+/CaM4 and (e) a phosphorylation site for phosphokinase C (PKC)5.
Secondly, single-cell patch-clamp studies reported that both rapid photo-release of caged Ca2+, rais-
ing [Ca2+]i to ~2 µM, and Ca2+ overspill from neighbouring Ca2+ channels, reduced peak Na+ currents, INa, 
in Nav1.4-transfected HEK293 cells and skeletal muscle cell lines. These effects were abrogated by intracellular 
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BAPTA6. Additionally, CaM expression in the transgenic cells negatively shifted the voltage-dependences of 
Nav1.4 inactivation. Both the reduction of peak INa, and this negative shift in voltage dependence, were abolished 
by mutations in either the Ca2+-binding-EF hands on CaM or the Nav1.4 C-terminal IQ domain2,6–8. These results 
implicated CaM binding to the IQ domain in Nav1.4 modulation by [Ca2+]i.
Thirdly, increases in free intracellular concentrations of FK506 binding protein, [FKBP12]i resulting from 
reductions in its affinity for RyR subunits associated with RyR opening9,10, positively shifted activation and 
inactivation voltage dependences in cardiomyocyte Nav1.511, thought closely homologous to Nav1.44. This 
likely involves an indirect effect; co-immunoprecipitation assays appear to exclude direct FKBP12–Nav1.5 
interactions11.
However, fewer reports are available on such [Ca2+]i-dependent Nav1.4 modulation in intact in situ skel-
etal myocytes. Loose-patch clamp studies reported that carbonyl cyanide-3-chlorophenylhydrazone12 
and 8-(4-chlorophenylthio)adenosine-3′, 5′-cyclic monophosphate challenge13 reduced INa. These effects 
were reversed by the Ca2+ buffer BAPTA and RyR blocker dantrolene respectively. However, these agents 
affected [Ca2+]i indirectly through modifying mitochondrial Ca2+ release or altering RyR activity through 
CAMKII-dependent pathways via Exchange protein directly activated by cAMP (Epac).
We here test the hypothesis that the direct RyR-SR Ca2+ channel modulator caffeine14 modifies INa in intact 
mammalian skeletal muscle fibres. We utilised experimental protocols previously shown to accomplish contrast-
ing effects of 0.5 and >1.0 mM caffeine challenge on spectrofluometrically measured resting skeletal myocyte 
[Ca2+]i15–17. Thus, in isolated rabbit skeletal SR or murine skeletal muscle fibre preparations, caffeine (0.5 mM) 
caused increased [Ca2+]i (to ~300 nM) from resting levels (typically ~106 ± 2 nM in rat gastrocnemius and 
soleus muscle fibres18). This was persistent over the subsequent 3–10 min intervals investigated15,16. In contrast, 
≥1.0 mM caffeine induced early [Ca2+]i peaks followed by reductions to persistently below-resting [Ca2+]i within 
80–90 sec16,17. The latter was attributed to a slow RyR inactivation reducing channel open probabilities taking 
place over seconds. This property was previously demonstrated in sheep and rabbit skeletal muscle RyRs recon-
stituted in lipid bilayers under levels of steady [Ca2+]i that would initially produce RyR activation (~10–100 µM)19.
The present experiments correspondingly investigated effects of 0.5 mM and 2.0 mM caffeine on INa in intact 
murine skeletal muscle using the loose-patch clamp approach. This employed relatively low-resistance seals (<2 
MΩ) with an undisrupted surface membrane thus leaving intracellular, particularly [Ca2+]i homeostasis unper-
turbed. In contrast, conventional tight-patch seals often include the Ca2+-sequestrating ethylene glycol-bis(βam-
inoethyl ether)-N, N, N’, N’-tetraacetic acid (EGTA) in intracellular pipette solutions. In addition, the loose-patch 
pipettes could be re-used between patches, permitting sequential and multiple recordings from the same cell 
before and after pharmacological challenge. This permitted standardized comparisons between successive results 
with the same pipette20. Test results were compared with effects of control challenges using the known specific 
RyR blocker dantrolene21 to identify caffeine effects specifically attributable to its direct RyR action.
Results
Currents obtained using the double pulse protocol. The experiments employed a loose-patch 
clamp preparation and recording layout fully described in the Materials and Methods section (Fig. 1). Voltage-
dependences of Na+ current, INa, including its activation and inactivation, were examined using a double test 
pulse protocol (Fig. 1D). In each sweep of the full protocol, the membrane was first held at resting membrane 
potential (RMP) for 5 ms. A hyperpolarising pre-pulse, duration 50 ms, imposed at times 5–55 ms from the begin-
ning of the sweep to voltage V0 = (RMP–40) mV, first removed any residual INa inactivation at the RMP. This 
standardized the proportion of activatable Na+ channels prior to application of the subsequent depolarising V1 
pulse, itself of duration 10 ms, at time 55–65 ms.
At early intervals immediately following solution change, a simplified protocol examined INa in individual 
patches. This averaged results from 5 sweeps of a pulse protocol imposing a single voltage step to a single voltage 
V1 at (RMP + 80) mV between 55 and 80 ms. INa features at later time intervals following solution change were 
studied using the full procedure. This examined effects of a family of V1 amplitudes varied between sweeps in 
+5 mV increments through test voltages between RMP and (RMP + 80) mV. This elicited currents reflecting the 
voltage dependence of INa activation. A further V2 pulse was then made to a constant, depolarised voltage of 
(RMP + 80) mV. This would activate all the Na+ channels within the patch not inactivated by the preceding V1 
pulse. This made it possible to explore the voltage dependence of Na+ current inactivation. For each value of V1, 
currents from 10 sweeps were averaged before examining the next value of V1. Each complete protocol applied to 
a single patch therefore involved collection of currents from 170 sweeps.
Figure 1E exemplifies currents obtained by a single sweep at a single voltage, V1 = (RMP + 35) mV following 
P/4 correction under control conditions. Downward, negative deflections denote inward while upward, positive 
deflections represent outward membrane currents. The V0 pulse typically yielded no currents. The V1 and associ-
ated V2 steps each elicited transient inward currents representing the opening and inactivation of Na+ channels. 
The magnitudes of their peaks, i1 and i2, were measured relative to the currents measured just before the respec-
tive V1 and V2 steps.
Each patch was only subjected to a single application of the complete set of pulse protocols. This made dif-
ferences between results arising from prolonged changes in the patch such as membrane blebbing unlikely22. 
Furthermore, following every set of sweeps a further bracketing protocol was then imposed using a single V1 step 
to RMP. The resulting average i2 value from the succeeding V2 step was then compared with the i2 value obtained 
by the first 10 sweeps of the preceding test protocol, for which V1 was also RMP. Patch stability was confirmed, 
permitting further analysis, if the bracketing i2 value was within 10% of the test i2 value. Thus, only patches with a 
stable seal, INa generation, and activation and inactivation characteristics were selected for further analysis.
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Early effects of caffeine on Na+ currents. The initial experiments explored for alterations in INa at the 
earliest times (1–4 min) following introduction of caffeine. The simplified protocol employing a single V1 test volt-
age of (RMP + 80) mV permitted prompt assessments of INa at times immediately following solution change. This 
made it additionally possible to explore the effects of using differing patch-clamping protocols either excluding or 
permitting caffeine access to membrane beneath the patch seal. All these manoeuvres first obtained control cur-
rents in the absence of caffeine (Fig. 2(A–D)(i)). The INa records showed increasing followed by decaying phases, 
conforming to previously established expectations of a voltage-dependent activation followed by more gradual 
inactivation of INa. In a first procedure, the patch pipette was then withdrawn, 0.5 mM caffeine was introduced, 
and the patch seal re-established 30 sec later. This procedure permitted caffeine access to membrane both beyond 
and within the patch seal, prior to further applications of the pulse procedures (Fig. 2A(i)). The challenge with 0.5 
caffeine then produced reductions in INa from the first minute of exposure (Fig. 2A(ii)).
A second procedure on a different patch employing a differing procedure yielded contrasting results. 
Following acquisition of control records (Fig. 2B(i)), 0.5 mM caffeine-containing extracellular solution was 
introduced whilst the pipette seal was maintained intact. Currents were similarly obtained at timed subsequent 
intervals. Here, the patch seal was accordingly continually maintained before, during and following introduction 
of caffeine-containing extracellular solution. This gave caffeine immediate access to membrane beyond but not 
within the patch seal. Challenge by 0.5 mM caffeine now produced little subsequent, early change in peak currents 
even with repeated INa determinations made at 1 min intervals between 1 to 4 minutes (Fig. 2B(ii)). In contrast, 
the effect of 0.5 mM caffeine in reducing INa could be finally restored in subsequent recordings made after lifting 
the patch pipette and restoring the patch seal 30 s later (Fig. 2B(iii)).
Figure 1. (A) Plan view of the muscle preparation after being pinned down at both ends in the bath. The 
soleus muscle (in grey) is overlaid by gastrocnemius. The shaded box in the centre represents the region of 
gastrocnemius fibres used for patch clamping. (B) Loose patch clamp experiment: Muscle preparation pinned 
down in KH solution. Pipette mounted at 45° to allow 90° contact of the bent tip with the fibre surface. The 
pipette is connected to a suction syringe13. (C) Equivalent circuit of loose patch clamp electrode on muscle 
membrane. Solution in the pipette clamped at Vpip. The voltage error arising from the flow of currents through 
the patch resistance (Rpatch) and the cell resistance (Rcell), along with the pipette resistance (Rpip) corrected 
mainly using a bridge circuit in the loose patch clamp amplifier13. (D) Complete set of pulse protocols carried 
out on a patch being investigated. This double test pulse protocol first superimposed a −40 mV hyperpolarising 
pre-pulse, lasting 50 ms, on the resting potential, RMP. This was followed by a depolarising V1 pulse varying in 
amplitude to test voltages between RMP and (RMP + 80) mV in +5 mV increments. This was followed by a V2 
pulse to a strongly depolarised potential of (RMP + 80) mV. (E) The corresponding current trace during a single 
sweep in the protocol under control conditions where V1 = (RMP + 35) mV, following P/4 protocol correction, 
giving peak currents I1 and I2.
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Separate experiments using 2.0 mM caffeine challenge gave concordant, complementary, results. Relative to 
the initial recordings in the absence of caffeine (Fig. 2C(i)), 2.0 mM caffeine initially produced a reduced INa, but 
this was rapidly succeeded by increased INa if the latter test recordings were made after lifting then restoring the 
patch seal (Fig. 2C(ii)). These effects were attenuated when the 2.0 mM caffeine was added then test recordings 
made whilst contrastingly maintaining an intact patch seal (Fig. 2D(i,ii)).
These findings suggested that both 0.5 and 2 mM caffeine reduced INa within the first minute of exposure. This 
reduction persisted over 1, 2 and 3 min with 0.5 mM caffeine, but was succeeded by a marked increase in INa with 
2 mM caffeine. However, such effects required a direct access of the caffeine to the area of membrane beneath the 
patch pipette in which INa was recorded. The subsequent explorations of caffeine effects on INa using the full pulse 
procedure at the later times accordingly challenged with caffeine prior to formation of the patch seal.
Figure 2. Results of simple pulse protocols to examine INa at early times following caffeine challenge using two 
experimental procedures. Following obtaining control records prior to caffeine challenge (A–D) panel (i), in 
(A), the patch electrode was withdrawn prior to introduction of 0.5 mM caffeine, and then restored prior to 
imposition of test steps (ii) in the following 1–3 min. In (B) the patch seal was maintained before, during and 
following introduction of 0.5 mM caffeine through imposition of the test steps (ii). The latter procedure was 
repeated following pipette withdrawal and restoration of the patch seal (iii). (C,D) adopted identical respective 
procedures as (A,B) using a 2 mM caffeine concentration.
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Effects on Ina magnitudes of 0.5 mM caffeine challenge. The INa recordings showed patterns that 
paralleled the previously reported contrasting [Ca2+]i changes produced by 0.5 and 2.0 mM caffeine concen-
trations. Figure 3 illustrates current records from families of voltage steps at differing V1 between RMP and 
(RMP + 80) mV under control conditions (A) and at different times following introduction of 0.5 mM caffeine 
(B). Initial rates of rise of current increased non-linearly with degree of depolarization elicited by the V1 steps. 
So did the peak INa which then reached a maximum at V1 ≈ (RMP + 75) mV before decreasing with further 
depolarisation. The subsequent V2 steps yielded currents whose peak INa decreased with increasingly positive V1 
consistent with prior voltage-dependent channel inactivation reducing the proportion of remaining activatable 
Na+ channels. The pulse protocols were repeated on different patches over successive time intervals following the 
introduction of caffeine. Figure 3B((i–iv)) illustrates typical families of traces obtained from 8, 20, 37 and 45 min 
following introduction of caffeine. Comparison of the successive sets of records suggested that peak INa initially 
showed marked, ~80%, reductions within the 10-minute interval following challenge (Fig. 3B(i–ii)). This was fol-
lowed by a recovery which then returned INa to pre-treatment levels over a >40 min time-course (Fig. 3B(iii–iv)).
Changes in the voltage dependence of Ina resulting from 0.5 mM caffeine challenge. Findings 
of this kind yielded INa current-voltage activation (I-V) and inactivation curves plotting dependences of peak 
Figure 3. Families of normalized current traces obtained from the double pulse protocol in response to caffeine 
challenge at a concentration of 0.5 mM in the absence (A,B) or presence (C,D) of 10 μM dantrolene. (A,C) 
Control traces obtained in KH solution, prior to caffeine challenge in the absence (A) or presence of dantrolene 
(C). (B,D) Families of records obtained at successive (i) 7–8 min, (ii) 20–21 min, (iii) 35–37 min and (iv) 
45–46 min intervals after addition of 0.5 mM caffeine-containing KH solution into the bath in the absence (B) 
or presence of dantrolene (D).
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INa on V1 in response to the respective V1 and V2 voltage steps. These are plotted for families of records obtained 
at different intervals following onset of caffeine challenge (Fig. 4). These curves demonstrated that compared to 
pre-treatment controls (Fig. 4A(i)), INa was reduced at 1–10, 11–25 and 26–40 min (Fig. 4A(ii–iv) respectively). 
However INa had recovered by the final (41–55 min) time interval (Fig. 4A(iv)). The maximum values of peak 
Figure 4. Activation (left panels) and inactivation I-V curves (right panels of each pair) (mean of I1 
or I2 ± standard error of mean (SEM) against each V1 excursion) in response to caffeine challenge at a 
concentration of 0.5 mM in the absence (A) or the presence (B) of 10 μM dantrolene. Experiments first obtained 
families of INa records before addition of caffeine in (A(i)), (B(i)). Families of INa records then obtained in 
intervals (ii) 1–10 minutes, (iii) 11–25 minutes (iv) 26–40 minutes and (v) 41–55 min intervals after adding 
0.5 mM caffeine.
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INa could be determined within the voltage range examined in the I-V curves obtained in the controls at 1–10 
and 41–55, but not 11–25 and 26–40 min. Accordingly, the same determinations were made under control con-
ditions and at 11–25, and 26–40 minutes with a modified pulse protocol (Fig. 5) that explored an increased V1 
range extending to (RMP + 120) mV and using a V2 step to (RMP + 100) mV. This encompassed the V1 at which 
maximum peak INa was observed, both under the control conditions (Fig. 5(i)) and at the selected times following 
addition of caffeine (Fig. 5(ii,iii)). Together the I-V plots suggested that the greatest peak INa occurred with depo-
larisations to (RMP + 105) mV at 11–25 min and at (RMP + 95) mV at 26–40 min respectively.
Figure 6A plots values of these parameters in successive patches with time following application of caffeine. 
Tables 1A and 2A list these parameters as means ± SEM from explorations grouped in successive time intervals 
as adopted in Fig. 3. This made it possible to test for statistically significant differences from the control findings 
obtained before addition of 0.5 mM caffeine. These demonstrated that within 1–10 min after adding caffeine, there 
was a sharp reduction in Imax. In addition, there was a negative shift in the V* value describing INa inactivation. In 
contrast, V* values for INa activation and k values for both activation and inactivation then remained unchanged. 
There then followed marked positive shifts in the V* of both INa activation and INa inactivation. The final INa 
recovery to pretreatment values, was then accompanied by more gradual negative shifts in the voltage depend-
ence of both INa activation and INa inactivation, with control Imax, and V* values regained at 26–40 and 41–55 min 
respectively. These changes in Imax and V* contrasted with the constant k values through these manoeuvres. 
Furthermore, they were abolished, as described fully below, by dantrolene-mediated RyR block.
Changes in magnitude and voltage dependence of Ina resulting from 2 mM caffeine chal-
lenge. Caffeine challenge at a 2 mM concentration gave contrasting INa changes. Following the initially 
decreased peak INa within 2 min described above (Fig. 2C), the pattern assumed a transient increase in INa fol-
lowed by its recovery to control levels. Figure 7 shows families of INa records obtained using the full pulse protocol 
as in Fig. 3 at the different times subsequent to 2.0 mM caffeine challenge. The current waveforms increased to 
a peak INa followed by an inactivating decline (Fig. 7A). However, the families of currents demonstrated mark-
edly greater INa at 2–15 min following exposure to 2 mM caffeine, in contrast to the reduction in INa produced 
by 0.5 mM caffeine. INa then progressively declined to pre-treatment levels over the succeeding time intervals 
Figure 5. Activation and inactivation I-V curves (mean of I1 or I2 ±standard error of mean (SEM) against 
each V1 excursion) for the (i) control condition prior to addition of caffeine, and (ii), 11–25 minutes and (iii) 
26–40 minutes after addition of 0.5 mM caffeine using an expanded range of V1 in the absence of dantrolene.
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(Fig. 7B(i–iii)). Figure 8A plots the resulting I-V and inactivation curves obtained at different time intervals, from 
which it was possible to obtain Imax, V* and k values for the I-V and inactivation curves. Figure 9 plots these values 
for successive patches with time following application of caffeine and Tables 3A and 4A summarise the statistical 
analysis of their means ± SEM from explorations in the successive time intervals, comparing these against the 
control pretreatment results.
The INa amplitudes, Imax, increased threefold over the 2–15 min following addition of caffeine when compared 
to its control values (Compare Fig. 8A(i,ii)). Imax then recovered in subsequent intervals to regain pre-treatment 
values at 26–40 minutes (Fig. 8A(iii,iv)). There were delayed negative shifts in the V* of both INa activation and 
INa inactivation at 16–25 min followed by smaller positive shifts at 26–40 min ((Fig. 9A(ii)); Tables 3A and 4A). 
Again, in common with findings using 0.5 mM caffeine, values of k showed relatively little change through these 
protocols.
Effect of dantrolene on the Ina responses to 0.5 and 2.0 mM caffeine. The final sequence of exper-
iments examined the effects of the specific RyR inhibitor dantrolene both by itself and on these divergent actions 
of 0.5 and 2.0 mM caffeine on INa using otherwise identical pulse protocols. Each experiment first obtained fam-
ilies of INa traces in the absence of all test agents in two successive patches studied within a first 10 min interval. 
The bath solution was then substituted for one containing 10 µM dantrolene and 2 further patches investigated 
within the next 10 minutes. The final INa records were then obtained after further replacing the bath solution with 
one containing both 0.5 or 2.0 mM caffeine and 10 µM dantrolene-containing solution. Patches were investigated 
using the same full pulse protocols as shown in Fig. 1.
Including dantrolene alone slightly increased peak INa (Figs. 3C and 7C). Analysis of the I-V relationships 
(Figs. 4B and 8B) accordingly demonstrated small but significant increases in activation and inactivation Imax 
compared to controls, but no effect on activation and inactivation V* and k values (Tables 5 and 6).
Simultaneous addition of dantrolene and 0.5 mM (Fig. 3C,D) or 2.0 mM caffeine (Fig. 7C,D) (Tables 1–4) 
resulted in currents whose magnitudes were similar to those obtained in the presence of dantrolene alone, at all 
the time intervals following the addition of caffeine. Dantrolene thus abrogated both the effects of 0.5 mM caffeine 
in producing transient decreases (Fig. 3D(i–iv)), and the effects of 2 mM caffeine in producing transient increases 
in INa (Fig. 7D(i–iii)). In parallel with the previous test experiments, I-V and inactivation relationships were 
Figure 6. Alterations in (i) Imax, (ii) V* and (iii) k derived from current-voltage (I-V) activation and inactivation 
curves followed from successive patches studied at different times before (t < 0 min) and following addition of 
0.5 mM caffeine in the absence (A) and presence (B) of 10 μM dantrolene.
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plotted for fibres studied in the presence of dantrolene and either 0.5 mM (Figs. 4B) or 2.0 mM caffeine (Fig. 8B) 
through the same time intervals as those used after challenge with 0.5 mM or 2.0 mM caffeine alone, respectively.
Figures 6B and 9B plot the resulting Imax, V* and k values for the I-V and inactivation curves for succes-
sive patches with time before, and following addition of either 0.5 (Figs. 6B) or 2 mM caffeine (Fig. 9B) in suc-
cessive individual patches exposed to dantrolene. None of these parameters showed the contrasting pattern of 
time-dependent changes in activation and inactivation parameters shown with 0.5 and 2 mM caffeine challenge 
in the absence of dantrolene. Tables 1–4 summarise the statistical analysis of their means ± SEM from explora-
tions in the successive time intervals comparing these (B) against the control pretreatment results (A). In both 
analyses the activation and inactivation Imax, V* and k values were respectively statistically indistinguishable from 
those obtained under dantrolene challenge alone when caffeine was absent. Again values of k remained constant 
through the experiments.
Neither challenge by dantrolene, nor that by caffeine, whether by itself or in combination with dantrolene, 
noticeably affected INa kinetics. When quantified by times to peak current at voltages yielding maximum INa in 
the I-V curves, control experimental groups subsequently used to test effects of dantrolene alone, or 0.5 or 2 mM 
caffeine in the absence of or following further dantrolene challenge, gave times of 0.49 ± 0.010, 0.48 ± 0.0093 
and 0.50 ± 0.012 ms respectively. Dunnett multiple comparison tests demonstrated that none of the subsequent 
interventions produced significantly alterations for all the time intervals assessed in Tables 1–4 (all P ≫ 0.05).
These control experiments thus demonstrate that (a) the RyR inhibitor dantrolene abrogated the contrast-
ing actions of either 0.5 mM or 2.0 mM caffeine in transiently decreasing or increasing INa with accompanying 
changes in V* to previously established altered RyR-mediated changes in [Ca2+]. (b) Their demonstration of an 
increased INa in the presence of dantrolene alone complements the demonstrations of increased INa produced by 
2 mM caffeine in suggesting some background inhibition of INa at even background resting [Ca2+]i.
Discussion
The present experiments explored for the existence of physiologically effective feedback loops between ryano-
dine receptor (RyR) activation by tubular depolarisation and Nav1.4 channel function that would thereby mod-
ify surface membrane excitability in skeletal muscle in vivo. This mechanism would complement feedforward, 
excitation-contraction-coupling, processes by which Nav1.4-mediated surface membrane depolarisation triggers 
RyR-mediated release of intracellularly stored sarcoplasmic reticular (SR) Ca2+. Feedback alterations in Nav1.4 
availability and/or voltage sensitivity are potentially physiologically important particularly under conditions 
Time after 
adding caffeine 
(min)
Imax, 
mean ± SEM 
(n- value), 
pA/µm2; 
p-value
V*, 
mean ± SEM 
(n -value), 
mV; p-value
k, 
mean ± SEM 
(n- value), 
mV; p-value
(A) Experiments performed with 0.5 mM caffeine, 0 μM dantrolene
Control 27.15 ± 0.971 (n = 13)
50.47 ± 0.721 
(n = 13)
6.720 ± 0.412 
(n = 13)
1–10
5.14 ± 1.448 
(n = 6)*
P < 0.0001
50.75 ± 0.749 
(n = 6)
P = 0.8182
7.90 ± 0.455 
(n = 6)
P = 0.1015
11–25
11.65 ± 1.964 
(n = 5)*
P < 0.0001
73.16 ± 2.099 
(n = 5)*
P < 0.0001
9.02 ± 0.286 
(n = 5)
P = 0.0546
26–40
15.30 ± 0.875 
(n = 5)*
P < 0.0001
57.33 ± 2.115 
(n = 5)*
P = 0.0011
8.07 ± 0.274 
(n = 5)
P = 0.0709
41–55
26.52 ± 1.970 
(n = 6)
P = 0.7466
47.45 ± 1.372 
(n = 6)*
P = 0.0461
6.72 ± 0.346 
(n = 6)
P = 0.9974
(B) Experiments performed with 0.5 mM caffeine, 10 μM dantrolene
Dantrolene alone 31.80 ± 1.086 (n = 8)
51.32 ± 0.703 
(n = 8)
6.55 ± 0.330 
(n = 8)
1–10
31.92 ± 0.516 
(n = 5)
P = 0.9322
51.70 ± 1.076 
(n = 5)
P = 0.7648
6.10 ± 0.297 
(n = 5)
P = 0.3714
11–25
31.77 ± 0.467 
(n = 5)
P = 0.9831
50.80 ± 0.720 
(n = 5)
P = 0.6365
6.86 ± 0.235 
(n = 5)
P = 0.5119
26–40
31.91 ± 0.448 
(n = 5)
P = 0.9401
52.08 ± 1.268 
(n = 5)
P = 0.5802
6.47 ± 0.359 
(n = 5)
P = 0.8808
41–55
31.27 ± 1.019 
(n = 5)
P = 0.7481
51.80 ± 0.797 
(n = 5)
P = 0.668
6.77 ± 0.112 
(n = 5)
P = 0.6148
Table 1. Mean Imax, V* and k values of activation I-V curves at increasing time intervals following addition of 
0.5 mM caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene. P values indicate significance 
of differences compared to control values. *Denotes a significant difference compared to controls where 
P < 0.05.
1 0Scientific RepoRtS |         (2020) 10:2199  | https://doi.org/10.1038/s41598-020-59196-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
of intense and prolonged muscle activation including tetanic stimulation and metabolic exhaustion. The lat-
ter changes could compromise SR Ca2+-ATPase activity through ATP depletion, thereby elevating [Ca2+]i. Any 
consequent effects of Ca2+ on Nav1.4 function would complement its other actions promoting slow RyR inac-
tivation19 and increasing sarcolemmal Ca2+-activated large conductance K+ channel (KCa1.1) conductance in 
downregulating excitation-contraction coupling23. Such feedback mechanisms would also bear on clinical con-
ditions affecting skeletal muscle excitability. K+-aggravated myotonia is associated with slowed INa kinetics and 
impaired INa inactivation that accompany Nav1.4 mutations in its EF-hand-like domain24. Other genetic, K+ 
and cold-aggravated myotonias are associated with reduced Ca2+-dependent Na+ channel inhibition similarly 
attributed to Nav1.4 mutations6. Finally, the weakness observed in dystrophic muscle is associated with elevated 
[Ca2+]i25.
The experiments here examined effects of direct pharmacological manipulation of RyR-mediated SR Ca2+ 
release by the RyR agonist caffeine14 on both Nav1.4 channel availability and its voltage-dependent activation 
and inactivation properties in intact skeletal myocytes. They utilised previously established contrasting effects of 
different applied caffeine concentrations on spectrofluometrically measured resting [Ca2+]i15,16. Low concentra-
tions of caffeine (0.5 mM) then increased [Ca2+]i persistently over the subsequent 3–10 min recording intervals in 
isolated rabbit skeletal SR or murine skeletal muscle fibre preparations15. In contrast, ≥1.0 mM caffeine induced 
early [Ca2+]i peaks rapidly followed by [Ca2+]i decreases below even resting-levels within 80–90 sec16,17.
Here, Na+ currents, INa were measured in intact mammalian gastrocnemius skeletal muscle using the loose 
patch clamp technique. This avoided membrane disruption and perturbations of [Ca2+]i homeostasis inherent in 
other experimental measurement procedures involving conventional cell-attached patch clamp studies, which 
additionally often include the Ca2+-sequestrating EGTA in the pipette solutions. Furthermore, the latter can 
require study of isolated or cultured cells with enzymatically treated membranes as opposed to the intact in 
situ skeletal myocytes examined here. The loose-patch configuration also permitted sequential and multiple 
recordings with the same standardized pipette in successive patches before and after pharmacological challenge 
as required in the present experiments26. The features of the resulting INa concurred with those obtained on ear-
lier occasions26 and with other voltage clamp methods applied to mammalian skeletal muscle27. The magnitude, 
voltage-dependence and quantified activation (current-voltage, I-V) and inactivation properties of INa were 
compared at different times following introducing caffeine. Further experiments blocking these effects with fur-
ther applications of the specific RyR inhibitor dantrolene attributed the observed changes specifically to altered 
RyR-mediated SR Ca2+ release.
Time after 
adding caffeine 
(min)
Imax, 
mean ± SEM 
(n-value), pA/
µm2; p-value
V*, 
mean ± SEM 
(n-value), 
mV; p-value
k, 
mean ± SEM 
(n-value), 
mV; p-value
(A) Experiments performed with 0.5 mM caffeine, 0 μM dantrolene
Control 26.24 ± 1.245 (n = 13)
30.22 ± 0.364 
(n = 13)
9.15 ± 0.217 
(n = 13)
1–10
4.50 ± 1.202 
(n = 6)*
P < 0.0001
22.27 ± 0.399 
(n = 6)*
P < 0.0001
9.00 ± 0.733 
(n = 6)
P = 0.8105
11–25
11.33 ± 1.959 
(n = 5)*
P < 0.0001
40.68 ± 1.843 
(n = 5)*
P < 0.0001
9.28 ± 0.516 
(n = 5)
P = 0.7797
26–40
16.09 ± 0.896 
(n = 5)*
P = 0.0002
26.71 ± 0.730 
(n = 5)*
P = 0.0002
9.31 ± 0.563 
(n = 5)
P = 0.7361
41–55
24.90 ± 1.614 
(n = 6)
P = 0.5421
24.03 ± 1.526 
(n = 6)*
P < 0.0001
9.00 ± 0.344 
(n = 6)
P = 0.7255
(B) Experiments performed with 0.5 mM caffeine, 10 μM dantrolene
Dantrolene alone 32.17 ± 1.225 (n = 8)
29.71 ± 0.555 
(n = 8)
9.62 ± 0.258 
(n = 8)
1–10
32.00 ± 1.535 
(n = 5)
P = 0.9305
27.97 ± 0.651 
(n = 5)
P = 0.071
9.77 ± 0.358 
(n = 5)
P = 0.7351
11–25
33.05 ± 0.913 
(n = 5)
P = 0.6227
30.38 ± 0.630 
(n = 5)
P = 0.4549
9.63 ± 0.286 
(n = 5)
P = 0.9975
26–40
32.55 ± 0.528 
(n = 5)
P = 0.8232
28.68 ± 1.154 
(n = 5)
P = 0.3855
8.48 ± 0.320 
(n = 5)
P = 0.187
41–55
32.52 ± 1.213 
(n = 5)
P = 0.8541
30.11 ± 1.056 
(n = 5)
P = 0.7191
10.12 ± 0.538 
(n = 5)
P = 0.3697
Table 2. Mean Imax, V* and k values of inactivation I-V curves at increasing time intervals following addition of 
0.5 mM caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene. P values indicate significance 
of differences compared to control values. *Denotes a significant difference compared to controls where 
P < 0.05.
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The observed contrasting alterations in INa closely paralleled the previously reported [Ca2+]i changes following 
caffeine challenge. Thus, INa was reduced early (1–2 min) following either 0.5 or 2 mM caffeine challenge. This 
effect was abrogated by reducing access of caffeine to tubular and therefore tubular-sarcoplasmic reticular triad 
regions in which RyRs are concentrated, in regions within the patch from which the recordings were obtained. 
The latter was accomplished by establishing patch seals before rather than after introduction of caffeine to the 
extracellular space. This would alter direct access of caffeine over a surface membrane area close to the 30 μm2 
cross sectional area of the electrode tip in contact with the membrane within which INa was recorded.
Subsequent recordings following the 0.5 and 2 mM caffeine challenge obtained by identical pulse protocols 
respectively demonstrated contrasting increases and decreases in peak INa followed by their recovery to pre-
treatment levels. These findings corroborate and extend previous independent reports that INa was reduced by 
Figure 7. Families of normalized current traces obtained from the double pulse protocol in response to caffeine 
challenge at a concentration of 2 mM in the absence (A,B) or the presence (C,D) of 10 μM dantrolene. (A,C) 
Control traces obtained in KH solution, prior to caffeine challenge. (B,D) Families of records obtained at 
successive (i) 3 or 5 min, (ii) 19 or 21 min and (iii) 29 or 31 min after addition of 2 mM caffeine-containing KH 
solution into the bath in (B) the absence or (D) presence of dantrolene.
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increased RyR activity following 8-CPT induced Epac pathway activation13. The INa changes were quantified by 
systematically exploring a consistent range of V1 test voltages thereby deriving families of INa records. These 
in turn yielded activation, I-V, and inactivation curves giving Imax, V* and k values. These respectively quan-
tified total available INa and the position and steepness of their voltage dependences. Sustained reductions in 
Imax induced by 0.5 mM caffeine paralleled the sustained [Ca2+]i increases previously reported following caffeine 
mediated activation of RyR-mediated SR Ca2+ release15. The increased INa observed in the presence of 2 mM 
Figure 8. Activation (left panels) and inactivation I-V curves (right panels) (mean of I1 or I2 ± standard error 
of mean (SEM)) against each V1 excursion before (i) and following (ii) introduction of 2 mM caffeine in the 
absence (A) or the presence (B) of 10 μM dantrolene. Families of INa records were obtained 2–15 min (ii), 
16–25 min (iii), and 26–40 min (iv) after adding 2 mM caffeine.
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Figure 9. Alterations in (i) Imax, (ii) V* and (iii) k derived from current-voltage (I-V) activation (left panels) 
and inactivation (right panels) followed from successive patches studied at different times before (t < 0 min) and 
following addition of 2 mM caffeine in the absence (A) and presence (B) of 10 μM dantrolene.
Time after 
adding caffeine 
(min)
Imax, 
mean ± SEM 
(n-value), pA/
µm2; p-value
V*, 
Mean ± SEM 
(n-value), 
mV; p-value
k, 
mean ± SEM 
(n-value), 
mV; p-value
(A) Experiments performed with 2 mM caffeine, 0 μM dantrolene
Control 26.87 ± 1.346 (n = 9)
51.01 ± 0.839 
(n = 9)
6.71 ± 0.518 
(n = 9)
2–15
75.56 ± 9.026 
(n = 7)*
P < 0.0001
49.99 ± 0.568 
(n = 7)
P = 0.3577
5.35 ± 0.130 
(n = 7)
P = 0.0507
16–25
41.07 ± 4.714 
(n = 4)*
P = 0.0023
45.70 ± 1.711 
(n = 4)*
P = 0.009
5.85 ± 0.622 
(n = 4)
P = 0.3531
26–40
27.18 ± 1.844 
(n = 5)
P = 0.8952
47.37 ± 1.087 
(n = 5)*
P = 0.0223
6.49 ± 0.159 
(n = 5)
P = 0.7647
(B) Experiments performed with 2 mM caffeine, 10 μM dantrolene
Dantrolene alone 31.80 ± 1.086 (n = 8)
51.32 ± 0.703 
(n = 8)
6.55 ± 0.330 
(n = 8)
1–15
31.14 ± 0.985 
(n = 6)
P = 0.6755
51.20 ± 0.643 
(n = 6)
P = 0.9072
6.31 ± 0.385 
(n = 6)
P = 0.6494
16–25
32.21 ± 1.186 
(n = 4)
P = 0.8186
51.94 ± 1.234 
(n = 4)
P = 0.6483
6.33 ± 0.374 
(n = 4)
P = 0.6954
26–40
31.17 ± 1.199 
(n = 5)
P = 0.7132
52.18 ± 0.650 
(n = 5)
P = 0.4217
6.02 ± 0.185 
(n = 5)
P = 0.2633
Table 3. Mean Imax, V* and k values of activation I-V curves at particular time intervals after addition of 2 mM 
caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene. P values indicate significance of 
differences compared to control values. *Denotes a significant difference compared to controls where P < 0.05.
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caffeine similarly paralleled reported contrastingly decreased [Ca2+]i attributed to slow RyR inactivation16,17. The 
latter findings further suggested significant inhibition of INa by even normal background [Ca2+]i.
These alterations in total available INa were accompanied by time-dependent changes in properties of the I-V 
and inactivation curves. With 0.5 mM caffeine challenge, the initial decreases in INa were accompanied by negative 
shifts in inactivation V* over 1–10 min. This was followed, over 11–25 min, by positive shifts in both INa activa-
tion and INa inactivation V*. The final INa recovery to pretreatment values between 26–55 min was accompanied 
by opposite, negative, shifts in activation and inactivation V*. With 2 mM caffeine challenge, the contrasting, 
Time after 
adding caffeine 
(min)
Imax, 
mean ± SEM 
(n-value), pA/
µm2; p-value
V*, 
Mean ± SEM 
(n-value), 
mV; p-value
k, 
mean ± SEM 
(n-value), 
mV; p-value
(A) Experiments performed with 2 mM caffeine, 0 μM dantrolene
Control 25.79 ± 1.713 (n = 9)
30.03 ± 0.343 
(n = 9)
9.00 ± 0.269 
(n = 9)
2–15
75.24 ± 7.502 
(n = 7)*
P < 0.0001
30.22 ± 0.507 
(n = 7)
P = 0.7513
8.39 ± 0.282 
(n = 7)
P = 0.1422
16–25
43.01 ± 5.505 
(n = 4)*
P = 0.0022
24.45 ± 0.437 
(n = 4)*
P < 0.0001
9.06 ± 0.605 
(n = 4)
P = 0.9101
26–40
26.40 ± 1.579 
(n = 5)
P = 0.8169
27.40 ± 1.458 
(n = 5)*
P = 0.0411
7.62 ± 0.398 
(n = 5)
P = 0.0719
(B) Experiments performed with 2 mM caffeine, 10 μM dantrolene
Dantrolene alone 32.17 ± 1.225 (n = 8)
29.71 ± 0.555 
(n = 8)
9.62 ± 0.258 
(n = 8)
1–15
31.43 ± 0.786 
(n = 6)
P = 0.6476
30.43 ± 0.755 
(n = 6)
P = 0.4431
9.05 ± 0.362 
(n = 6)
P = 0.2069
16–25
32.48 ± 1.056 
(n = 4)
P = 0.8756
28.44 ± 0.925 
(n = 4)
P = 0.238
9.20 ± 0.165 
(n = 4)
P = 0.3059
26–40
32.38 ± 0.595 
(n = 5)
P = 0.9029
29.06 ± 0.811 
(n = 5)
P = 0.509
9.19 ± 0.393 
(n = 5)
P = 0.358
Table 4. Mean Imax, V* and k values of inactivation I-V curves at particular time intervals after addition of 2 mM 
caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene. P values indicate significance of 
differences compared to control values. *Denotes a significant difference compared to controls where P < 0.05.
Condition
Imax, 
mean ± SEM 
(n-value), pA/
µm2; p-value
V*, 
mean ± SEM 
(n-value), mV; 
p-value
k, mean ± SEM 
(n-value), mV; 
p-value
Control 27.67 ± 0.881 (n = 8)
51.39 ± 0.528 
(n = 8)
5.92 ± 0.221 
(n = 8)
Dantrolene
31.80 ± 1.086 
(n = 8)*
P = 0.0105
51.32 ± 0.703 
(n = 8)
P = 0.9346
6.55 ± 0.330 
(n = 8)
P = 0.1372
Table 5. Mean Imax, V* and k values of activation I-V curves before and after addition of 10 μM dantrolene. 
P values indicate significance of differences compared to control values. *Denotes a significant difference 
compared to controls where P < 0.05.
Condition
Imax, 
mean ± SEM 
(n-value), pA/
µm2; p-value
V*, 
mean ± SEM 
(n-value), mV; 
p-value
k, mean ± SEM 
(n-value), mV; 
p-value
Control 27.66 ± 1.075 (n = 8)
29.64 ± 0.5001 
(n = 8)
8.824 ± 0.4387 
(n = 8)
Dantrolene
32.17 ± 1.225 
(n = 8)*
P = 0.0151
29.71 ± 0.5547 
(n = 8)
P = 0.9321
9.623 ± 0.2582 
(n = 8)
P = 0.1386
Table 6. Mean Imax, V* and k values of inactivation I-V curves before and after addition of 10 μM dantrolene. 
P values indicate significance of differences compared to control values. *Denotes a significant difference 
compared to controls where P < 0.05.
1 5Scientific RepoRtS |         (2020) 10:2199  | https://doi.org/10.1038/s41598-020-59196-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
declining phases of the transient INa increases accompanied delayed transient negative shifts in both activation 
and inactivation V*. In contrast, values of k of either activation or inactivation little changed throughout these 
protocols.
Finally, the effects of the specific RyR inhibitor dantrolene were investigated both by itself and in combination 
with identical caffeine concentrations and pulse protocols. Dantrolene specifically stabilises RyR closed states by 
selectively decreasing Ca2+ affinities of RyR activation sites21. Previous reports had demonstrated that it inhibited 
caffeine-induced increments in mammalian SR Ca2+ permeability28 and caffeine-induced contractures in murine 
diaphragm muscle29.
In the present experiments dantrolene abrogated all the effects of either 0.5 or 2 mM caffeine, whether on 
Imax, or activation or inactivation INa or V*. In contrast, dantrolene by itself produced only small increases in Imax 
without affecting activation and inactivation, V* and k values. Together with the increased INa produced by 2 mM 
caffeine this latter finding suggests that [Ca2+]i exerts significantly inhibits INa even at background RyR activity. 
These explorations using dantrolene thus trace all the present actions of caffeine on INa specifically to its effects on 
RyR-mediated SR Ca2+ release.
These findings together demonstrate and characterise RyR-Nav1.4 feedback phenomena complementing 
their established feedforward interactions underlying excitation contraction coupling (Fig. 10A). The observed 
contrasting effects of caffeine challenge on Imax and V* combined with previously reported [Ca2+]i changes 
under similar experimental conditions15–17 were incompatible with straightforward combined negative shifts in 
Na+ channel activation and inactivation V* resulting from simple screening effects arising from an increased 
[Ca2+]i30,31. However, they directly correlate with previous in vitro biochemical and biophysical reports on skeletal 
muscle Nav1.4 and RyR. They establish for these a physiological context, possibly occurring within a common 
microdomain, in working muscle, as opposed to in vitro systems for the first time.
First, the early INa reductions with 0.5 and 2 mM caffeine, persistent with 0.5 mM caffeine, were consistent with 
the reported effects of either direct Ca2+-binding to a Nav1.4 EF hand site or indirect Ca2+ binding to Nav1.4 via 
its binding to CaM in reducing INa (Fig. 10C). Secondly, the accompanying early negative V* shifts 1–10 min fol-
lowing 0.5 mM caffeine challenge paralleled reported negative shifts in voltage-dependent inactivation produced 
Figure 10. Correlation between observed ryanodine receptor (RyR) agonist and antagonist actions and (A) 
Feedforward Nav1.5 mediated depolarisation triggering DHPR-RyR coupling causing SR Ca2+ release that is 
(B) inhibited by RyR-antagonist dantrolene, and previous studies reporting: (C,D) Challenge by (C) 0.5 mM 
caffeine increasing RyR-mediated Ca2+ release and FKBP12 dissociation reducing Nav1.4 availability thereby 
modifying Nav1.4 properties and (D) 2 mM caffeine, where Ca2+ release causes sustained RyR inactivation with 
net SR Ca2+ uptake, reduced FKBP12 dissociation, and contrasting Nav1.4 effects. Blue arrows: fluxes; green and 
red dotted arrows: excitatory and inhibitory actions.
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by the indirect Ca2+ binding process2,6–8. This was selective for Nav1.4 as opposed to Nav1.5, reflecting Nav1.4 
lacking the CaM N-lobe binding site present in Nav1.51. Thirdly, the subsequent (11–25 min) positive shifts in 
INa activation and inactivation V* directly paralleled reported reductions in FKPB12 binding affinity for RyR 
following RyR activation. An increased free [FKBP12]i would then accompany the resulting SR Ca2+ release ele-
vating [Ca2+]i. in intact fibres9,10; FKBP12 is known to positively shift V* activation and inactivation in Nav1.511, 
thought closely homologous to Nav1.44. This action is probably indirect and delayed: co-immunoprecipitation 
assays appeared to exclude direct FKBP12–Nav1.5 interactions11. Fourthly, negative shifts in both INa activation 
and inactivation V* values eventually accompanied the reductions in INa and recoveries from INa elevation, 26–55 
or 16–40 min following 0.5 and 2.0 mM caffeine challenge respectively. These were compatible with a subsequent, 
previously reported, slow RyR inactivation19. This would reduce RyR open channel probabilities and Ca2+ release 
whilst permitting continued SR Ca2+ re-uptake and possible surface membrane Ca2+ expulsion by Na+/Ca2+ 
exchange32,33. These would reverse the increases in [Ca2+]i and [FKBP12]i19 (Fig. 10D). Finally, the effects of the 
RyR inhibitor dantrolene (Fig. 10B) abrogating all these contrasting reductions and increases in INa associated 
with different caffeine concentrations through the identical pulse protocols associated all these findings with 
feedback effects arising specifically from the RyR.
Materials and Methods
Experiments were performed under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 
following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB). 
C57BL6 WT mice aged 3–6 months were used in all experiments. Mice were housed at a stable temperature of 
21 °C in a licensed facility, fed sterile rodent chow (RM3 Maintenance Diet; SDS, Witham, United Kingdom) 
and subjected to 12-hour light/dark cycles with free access to water, bedding and environmental stimuli. 
Krebs–Henseleit (KH) solution (mmol/L: NaCl, 130; KCl, 4.0; HEPES, 1.2; MgCl2, 1.0; CaCl2, 1.8; glucose, 10; 
and Na-pyruvate, 2.0; pH adjusted to 7.4) was used in all experiments. Chemical agents were purchased from 
Sigma-Aldrich (Poole, UK) unless otherwise stated. The following variants of the basic KH solution containing 
caffeine and/or dantrolene including 0.1% dimethyl sulfoxide vehicle were prepared and used in experiments: 
(1) KH + 0.5 mM caffeine, (2) KH + 2.0 mM caffeine, (3) KH + 10 µM dantrolene, (4) KH + 10 µM dantro-
lene + 0.5 mM caffeine, and (5) KH + 10 µM dantrolene + 2.0 mM caffeine. Solutions were filtered to remove par-
ticles greater than 10 μm in diameter with standard filtration paper (Millipore, Bedford, MA, USA).
Mice were killed by cervical dislocation by Home Office-licensed personnel in accordance with Schedule 1 of 
The Animals (Scientific Procedures) Act 1986. The gastrocnemius and soleus muscles were then immediately iso-
lated, with the distal (Achilles) tendon secured by a knot to a ligature and the proximal tendon still attached to its 
bony origin. Overlying connective tissue was excised to allow access to the myocyte surface. The isolated muscles 
were then immediately placed in a Sylgard-bottomed experimental bath containing KH solution with the soleus 
muscle facing down maximizing electrode access to gastrocnemius fibres. Experiments were carried out at stable 
temperatures around 20 °C. The muscle was secured in a taut and fixed position by pinning down the bony origin 
and the ligature with A1 insect pins (Fig. 1A).
Loose patch clamp pipettes were pulled from borosilicate glass capillaries (GC150‐10; Harvard Apparatus, 
Cambridge, UK) using a Brown–Flaming microelectrode puller (Model P‐97; Sutter Instrument Co. Novato, 
CA). They were mounted under a microscope with ×250 magnification with a calibrated eyepiece graticule, and 
a small indentation made on one side of the pipette using a diamond knife. A transverse force was then applied 
distal to the indentation, giving a fracture perpendicular to the long axis of the pipette. Squarely-broken tips were 
then fire‐polished under visual guidance at ×400 magnification using an electrically-heated nichrome filament 
to smooth the edges of the tip. The internal diameters of the pipettes were measured under ×1000 magnification. 
Pipettes of internal tip diameters between 28–38 µm were used in the experiments. Such loose patch recordings 
thus provide a complete representation of the properties of both surface and tubular membrane directly beneath 
these seals. Finally, the pipettes were bent at about 1 mm from the tip to make a 45° angle with the pipette’s long 
axis. This allowed the tips to contact the muscle surface at 90° when mounted at an angle of 45° below the hori-
zontal on the recording amplifier head stage (Fig. 1B). The pipettes were mounted onto a pipette holder with 
an Ag/AgCl electrode held within the inside of the pipette. The distal half of the pipette was filled with solution 
from the bath, using suction provided by a syringe via an air-filled connection to the pipette holder. The bath 
was actively grounded at reference potential, using an Ag/AgCl electrode. These Ag/AgCl electrodes maintained 
electrical connection between the organ bath and pipette with the electronic circuit.
The pipette was lowered onto the gastrocnemius muscle membrane surface and gentle suction applied to allow 
seal formation around the resulting membrane patch. The central regions of the muscle (crosshatched region in 
scheme shown in Fig. 1A) were targeted for each experiment as this region was the most horizontal, permitting 
optimal (~90°) contact between pipette tip and muscle. The loose patch clamp configuration clamps the voltage 
on the extracellular side of the membrane within the pipette seal. Therefore, positive and negative potentials 
applied within the pipette respectively hyperpolarise and depolarise the membrane potential of the patch relative 
to the cell resting membrane potential (RMP). In this report, the signs of the voltage steps are inverted and mem-
brane potentials expressed relative to RMP, a convention adopted by previous papers using this technique12,13,20,26. 
The Ag/AgCl electrode within the pipette both measured the intra-pipette potential relative to the ground refer-
ence potential of the bath and passed the clamp current.
Figure 1C shows the equivalent circuit of a typical patch. The loose patch technique involves a relatively low 
seal resistance (typically < 2 MΩ). This ohmic leakage and series resistance error [(seal resistance + patch resist-
ance) and pipette resistance], along with additional pipette capacitance currents were largely corrected by a bridge 
circuit within the loose patch clamp amplifier26. The remaining linear leakage and capacitive currents were cor-
rected using a P/4 protocol in which the test steps were followed by four control voltage steps a quarter the ampli-
tude and of opposite signs to the test step. These were of a sign and/or amplitude that did not activate the voltage 
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conductances, hence only eliciting leak currents. These responses were measured, summed and subtracted from 
the current values obtained from the original test step within the loose patch clamp26.
An IBM-compatible computer connected to the loose patch clamp amplifier, which was connected to the 
headstage that held the recording pipette was used to deliver voltage clamp steps relative to the RMP. Study of 
each patch commenced with strongly depolarising +80 mV, 15 ms pulses in order to confirm the presence of ion 
channels. Only patches showing clear, resolvable inward currents with kinetics characteristic of voltage-gated 
Na+ channels were investigated with the full set of pulse protocols. The patch clamp currents were sampled by 
the computer at a 50 kHz digital sampling rate and filtered with a DC-10 kHz bandwidth, using a 10 kHz Bessel 
low pass filter.
Experiments were initially performed with the muscle preparation immersed in control KH solution. Around 
2–3 different patches were investigated using the complete set of pulses within 20 minutes after transferring the 
muscle preparation into the bath. Only muscles that gave stable control results were further studied in the pres-
ence of pharmacological challenge. For each pharmacological condition, data from patches collected from at least 
3 muscle preparations were used. To achieve conditions comparable to previous studies on [Ca2+]i, the bathing 
solution was then rapidly replaced with KH solution containing either 0.5 mM and 2.0 mM caffeine. The resulting 
effects on Na+ current amplitude, and activation and inactivation characteristics were then examined at increas-
ing times from a sequence of different patches following onset of caffeine challenge. Averaged currents from the 
10 sweeps obtained for each pulse voltage within the experimental protocol were then normalised to the pipette 
tip cross-sectional area to give current densities, using the formula relating current density (in pA/µm2), meas-
ured current (in nA) and pipette diameter (in µm):
µ µCurrent density(pA/ m ) {measured current(nA) 4000}/{ [pipette diameter( m)] }2 2π= × ×
The resulting peak I1 and I2 current densities obtained from the V1 and V2 steps in the double pulse protocols 
generated activation and inactivation current-voltage (I-V) curves, respectively, for each patch. The rising phase 
of the activation I-V curve for each patch was fitted to a two-state Boltzmann function relating the peak current 
density for any V1 excursion (I1) to its maximum value (Imax), the voltage at half maximal peak current (V*), the 
excursion corresponding to the V1 step (V) and the steepness factor (k): I1 = Imax/[1 + exp{(V* − V)/k}]). The 
inactivation I-V curves were fitted to a similar Boltzmann function relating the peak current density I2 for the V2 
step following any given V1 excursion to its maximum value (Imax), the voltage at half maximal current (V*), the 
excursion of the V1 step (V) and a steepness factor (k): I2 = Imax(1 − 1/[1 + exp{(V* − V)/k}]).
Successive families of ionic currents revealed alterations in current characteristics with time following caffeine 
challenge. These are represented by displaying currents, current-voltage curves and computed values of Imax, V* 
and k as obtained from each patch averaged to give means ± SEM for currents obtained within successive time 
intervals following introduction of pharmacological agents. Curve fitting procedures of the I-V curves used fitting 
algorithms in the open source programme SciDAVis (Version 1.25-mac). Derived parameters obtained under dif-
ferent conditions were tested for significant differences to a P < 0.05 significance level by ANOVA with a post-hoc 
Dunnett’s test.
Ethical approval. This research has been regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review and approval by the University of Cambridge Animal 
Welfare and Ethical Review Body (AWERB). All procedures were completed by Home Office-licensed personnel 
and fell within the scope of Schedule 1 of the UK Animals (Scientific Procedures) Act (1986).
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The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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